Agenda Items ▸ Resolutions
RES 2017-385
Congratulations to Summit Therapeutics for being awarded a $62 million contract from US Department of Health and Human Services’ Biomedical Advanced Research and Development to support development of Support development of ridinilazole for C. difficile infection
How it started
Sep 18, 2017 · Offered by Councillor Leland Cheung.
What happened
Sep 18, 2017 · 🎉 Adopted: the Council approved it. (Order adopted · one not recorded)
Present and voting at this meeting (8)
- David Maher
Dennis Carlone
E. Denise Simmons
Jan Devereux- Leland Cheung
Marc McGovern- Nadeem Mazen
Timothy J. Toomey
What’s next
🚪 End of the line: congratulations delivered.